Sign in
CompletedNo phase

C-SMART: Cognitive Strategies, Mindfulness, and Rehabilitation Therapy for Patients With Primary Brain Tumors

Key facts

Who runs it
Virginia Commonwealth University
Where
Richmond, United StatesSee the site
Trial code
Status
Completed
People taking part
32 people enrolled
Started
15 Sept 2023
Ended
23 Jul 2025
Type of study
Observational, 2 groups
Treatments tested
  • C-SMART
Record updated
20 February 2026

Who can take part

Age
18 years and older
Sex
Women and men
Healthy volunteers
Cannot take part

The registry criteria, word for word

Show all 15 criteriaShow less

Other criteria

  • Patient Inclusion Criteria:
  • Confirmed primary brain tumor diagnosis by histology or neuro-oncologist review of imaging
  • At least one domain of neurocognitive function >1.5 SD below the average or the individual's estimated premorbid functioning, using the expanded ICCTF clinical trials battery and Test of Premorbid Functioning for comparison
  • >1 month post brain surgery and/or radiation therapy, if applicable
  • Estimated premorbid intelligence >75
  • Patients must be age 18+ and primarily English speaking; Patient Exclusion Criteria:
  • Presence of major neurocognitive impairment that would prevent participation in the intervention, and/or severe aphasia, and/or inability to understand and provide informed consent
  • Inability to attend weekly telehealth appointments; based on EAB results
  • Clinically significant insomnia symptoms
  • < 1 month post brain surgery and/or radiation therapy
  • Unstable internet connection or an inability to work teleconferencing software. Participants will be supplied an iPad if they do not have an adequate device
  • To participate in the fMRI portion of this study participants cannot have any metal in their bodies. For the fMRI subset, participants cannot have metal in their body as the MRI scan could cause them harm and if female of childbearing years, they cannot be pregnant as the MRI scan may pose risk to the unborn fetus; Caregiver Inclusion Criteria
  • Must be an adult caregiver of an enrolled patient (see criteria above)
  • Primarily English speaking; Caregiver Exclusion Criteria
  • Paid caregiver (e.g. home health aide)

Where in United States

  • Virginia Commonwealth UniversityRichmond, United States

About the trial

What the trial wants to find out

The goal of Phase Ib Trial is to determine the feasibility and acceptability of telehealth C-SMART for patients with primary brain tumor and mild neurocognitive deficits (N=18) and their caregivers (N=14) A subset (n=3) of participants will undergo rs-fMRI both pre- and post-C-SMART to test feasibility of advanced functional imaging in this population.

The 2 groups in the trial

  • Patient

    C-SMART intervention will be provided via telehealth. Participants will complete in-person neurocognitive testing (baseline, post-intervention) as well as surveys (baseline, post-session, post-intervention) via secure email link. Exit interviews will be conducted by Zoom.

    Treatment: C-SMART

  • Caregiver

    Informal caregiver that may enroll with the patient (not required)

    Treatment: C-SMART

Data and sources

Registry record
Listed on ClinicalTrials.gov.
Official title
C-SMART for Patients With Primary Brain Tumors: A Feasibility and Acceptability Pilot of a Novel Neuropsychological Intervention
Record updated
20 February 2026